Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective. | Cancers (Basel) | 2021 | 34944834 | PubTator, text mining | PubMed |
| Proliferation Cycle Transcriptomic Signatures are Strongly associated With Gastric Cancer Patient Survival. | Front Cell Dev Biol | 2021 | 34926458 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| Endometrial cancer. | Nat Rev Dis Primers | 2021 | 34887451 | PubTator, text mining | PubMed |
| A link between mitotic defects and mitotic catastrophe: detection and cell fate. | Biol Direct | 2021 | 34886882 | PubTator, text mining | PubMed |
| BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. | Molecules | 2021 | 34885726 | PubTator, text mining | PubMed |
| Mad2 Induced Aneuploidy Contributes to Eml4-Alk Driven Lung Cancer by Generating an Immunosuppressive Environment. | Cancers (Basel) | 2021 | 34885137 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis. | Cancers (Basel) | 2021 | 34885040 | PubTator, text mining | PubMed |
| Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma. | Front Cell Dev Biol | 2021 | 34869385 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas. | Front Oncol | 2021 | 34868937 | PubTator, text mining | PubMed |
| Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort. | Front Mol Biosci | 2021 | 34859058 | PubTator, text mining | PubMed |
| Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification. | Front Pharmacol | 2021 | 34858165 | PubTator, text mining | PubMed |
| Counteraction between Astrin-PP1 and Cyclin-B-CDK1 pathways protects chromosome-microtubule attachments independent of biorientation. | Nat Commun | 2021 | 34853300 | PubTator, text mining | PubMed |
| SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma. | Int J Gen Med | 2021 | 34849004 | PubTator, text mining | PubMed |
| Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer. | Bioengineered | 2021 | 34845974 | PubTator, text mining | PubMed |
| Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma. | Cancer Cell Int | 2021 | 34838000 | PubTator, text mining | PubMed |
| Beyond HAT Adaptor: TRRAP Liaisons with Sp1-Mediated Transcription. | Int J Mol Sci | 2021 | 34830324 | PubTator, text mining | PubMed |
| Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer. | Int J Mol Sci | 2021 | 34830174 | PubTator, text mining | PubMed |
| Developmental Acquisition of p53 Functions. | Genes (Basel) | 2021 | 34828285 | PubTator, text mining | PubMed |
| Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. | Technol Cancer Res Treat | 2021 | 34825846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=34